Congress·In Committee·S. 3188

Biomanufacturing: National Center of Excellence

Biomanufacturing Excellence Act of 2025

Legislative Progress

Senate

House

President

Law

This bill would create a National Biopharmaceutical Center of Excellence to help American companies turn lab discoveries into mass-produced medicines. The goal is to provide the expensive equipment and space needed to prove that new treatments can be made safely and efficiently on a large scale.
By investing in local manufacturing, the policy aims to make the United States less dependent on foreign countries for its medicine supply. This is seen as a way to protect national health and security by ensuring critical drugs are made right here at home.
The plan includes $120 million in funding for the 2026 budget year. This money would go toward building new facilities, conducting research on how to make drugs faster, and creating training programs to help workers learn the skills needed for high-tech biotech jobs.

2 milestones2 actions

Nov 18, 2025Senate

Read twice and referred to the Committee on Commerce, Science, and Transportation.

Nov 18, 2025

Introduced in Senate

1 bill

Biomanufacturing Excellence Act of 2025

Nov 18 — Referred to the House Committee on Science, Space, and Technology.

Document Type

Congressional Bill

Official Title

Biomanufacturing Excellence Act of 2025

Bill NumberS 3188

Congress119th Congress

ChamberSenate

Latest ActionRead twice and referred to the Committee on Commerce, Science, and Transportation.

(3)

D: 1R: 2

Congress.gov

Official legislative information

Analysis generated by AI. Always verify with official sources.